Skip to content

Medical-device intelligence

GFO: Activated Partial Thromboplastin

FDA product code GFO: Activated Partial Thromboplastin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GFO
FDA device name
Activated Partial Thromboplastin
Device class
2
Regulation number
864.7925
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

52 clearance records and 10 recall records in the covered releases, across 37 source company names and 1 product codes. Dated history runs from Aug 3, 1976 to Jan 9, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202501
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GFO · Activated Partial Thromboplastin5210

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

62 matching records
Device / recordCompany in FDA recordSourceSource date
The product is used for the evaluation of the intrinsic coagulation pathway, APTT substitution test and the monitoring of heparin therapy.Z-1095-2026 · GFOInstrumentation LaboratoryRecallJan 15, 2026FDA classification date
HemosIL Silica Clotting TimeK253957 · GFOInstrumentation Laboratory (IL) Co.510(k)Jan 9, 2026FDA decision date
HemosIL SynthAFax. Partial Thromboplastin Time Tests.Z-0938-2026 · GFOInstrumentation LaboratoryRecallDec 17, 2025FDA classification date
Cascade Abrazo aPTT Test Card - Product Usage: are to be used with the Cascade Abrazo analyzer and are intended for the determination of the acti…Z-1108-2021 · GFOHelena Laboratories, Corp.RecallFeb 11, 2021FDA record creation date
Cryocheck Hex LAK193556 · GFOPrecision Biologic510(k)Oct 23, 2020FDA decision date
Cascade Abrazo aPTT Test Card, Model 5722, For Export Only. The firm name on the label is Helena Laboratories, Beaumont, TX.Z-2761-2019 · GFOHelena Laboratories, Corp.RecallSep 27, 2019FDA classification date
Staclot LA (REF 00600) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagu…Z-0610-2019 · GFODiagnostica Stago, Inc.RecallDec 14, 2018FDA record creation date
Staclot LA 20 (REF 00594) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus antico…Z-0611-2019 · GFODiagnostica Stago, Inc.RecallDec 14, 2018FDA record creation date
HemosIL Silica Clotting TimeK160445 · GFOInstrumentation Laboratory CO510(k)Mar 16, 2016FDA decision date
Dade Actin Activated Cephaloplastin Reagent; Liquid rabbit brain cephalin with plasma activator for use in the determination of the activated par…Z-1703-2015 · GFOSiemens Healthcare Diagnostics, Inc.RecallJun 2, 2015FDA classification date
Hemochron Jr. Citrate APTT Cuvette 510(k) K014008 A unitized microcoagulation test intended to be used in performing a quantitative, one -stage A…Z-0937-2014 · GFOITC-Nexus DxRecallFeb 6, 2014FDA classification date
Staclot LA 20 tests, Catalog #0594, LA Assay, Hexagonal Phase Phospholipid Neutralization Assay.Z-1441-06 · GFODiagnostica Stago, Inc.RecallAug 26, 2006FDA classification date
STA-CEPHASCREEN KITK053111 · GFODiagnostica Stago, Inc.510(k)May 4, 2006FDA decision date
HEMOSIL SYNTHASILK060688 · GFOInstrumentation Laboratory CO510(k)Apr 13, 2006FDA decision date
HEMOSIL SILICA CLOTTING TIMEK050221 · GFOInstrumentation Laboratory CO510(k)Mar 30, 2005FDA decision date
Pathromtin SL. Partial Thromboplastin Time Tests. The product is sold in kits containing 10 and 20 vialsZ-0773-04 · GFODade Behring , Inc.RecallJul 20, 2004FDA classification date
VITAL SCIENTIFIC APTT, APTT & QUIKCOAG APTTK022021 · GFOVital Scientific N.V.510(k)Nov 1, 2002FDA decision date
CARESIDE APTTK014028 · GFOCareside Hemotology, Inc.510(k)Feb 8, 2002FDA decision date
HEMOCHRON JR. CITRATE APTT CUVETTEK014008 · GFOItc, Inc.510(k)Jan 24, 2002FDA decision date
SIGMA DIAGNOSTICS ALEXIN HS, MODELS A0969, A1094K992711 · GFOSigma Diagnostics, Inc.510(k)Dec 6, 1999FDA decision date
SIGMA DIAGNOSTICS ALEXIN LS, MODELS A1219, A1334K992712 · GFOSigma Diagnostics, Inc.510(k)Dec 6, 1999FDA decision date
HEMOCHRON CITRATE APTTK972831 · GFOInternational Technidyne Corp.510(k)Nov 20, 1997FDA decision date
IL TEST APTT-SPK973306 · GFOInstrumentation Laboratory CO510(k)Nov 4, 1997FDA decision date
SPECKTIN-LA TEST SETK961892 · GFOAnalytical Control Systems, Inc.510(k)Mar 7, 1997FDA decision date
SYNTHAFAX APTT REAGENTK955638 · GFOOrtho Diagnostic Systems, Inc.510(k)Apr 23, 1996FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗